Internal Medicine · Allentown, PA
NPI
1528145620
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
451 Chew St, Sutie 404
Allentown, PA, 18102
Phone (610) 973-3391
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
674 services
Medicare patients, 2024
19
Average age 72
Drug cost, 2024
$2.5M
8,646 prescriptions
Company payments, 2025
$622
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria C Erazo was code 99458 (e&m - miscellaneous), 130 times for 16 patients. In total Maria C Erazo billed 674 services in 33 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 130 | 16 | $28.14 | $3,658 |
| 99457 E&M - Miscellaneous | Office | 69 | 16 | $34.79 | $2,401 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 61 | 15 | $94.99 | $5,794 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 61 | 15 | $51.53 | $3,144 |
| 99215 Office E&M - Established | Office | 60 | 13 | $127.00 | $7,620 |
| 82962 Clinical Chemistry | Office | 33 | 12 | $3.21 | $106 |
By year: 2022 $77K for 1,671 services; 2023 $49K for 1,063 services; 2024 $33K for 674 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 33 | 12 | $3.21 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria C Erazo prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 424 prescriptions and refills. In total Maria C Erazo wrote 8,646 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 424 | 495 | 72 | $517K |
| Rosuvastatin Calcium Generic | 362 | 551 | 83 | $4,757 |
| Famotidine Generic | 324 | 461 | 60 | $2,754 |
| Ezetimibe Generic | 311 | 454 | 56 | $5,534 |
| Kerendia Finerenone | 284 | 400 | 55 | $249K |
| Bromocriptine Mesylate Generic | 266 | 393 | 51 | $8,145 |
| Levothyroxine Sodium Generic | 232 | 349 | 45 | $1,184 |
| Metformin Hcl Generic | 232 | 337 | 53 | $1,014 |
| Farxiga Dapagliflozin Propanediol | 218 | 294 | 39 | $163K |
| Icosapent Ethyl Generic | 204 | 272 | 38 | $29K |
| Jardiance Empagliflozin | 200 | 291 | 36 | $166K |
| Diclofenac Sodium Generic | 194 | 306 | 53 | $4,363 |
| Atorvastatin Calcium Generic | 194 | 303 | 46 | $1,367 |
| Olmesartan Medoxomil Generic | 183 | 287 | 56 | $2,273 |
| Amlodipine-Olmesartan Amlodipine Bes/Olmesartan Med | 178 | 255 | 43 | $7,274 |
Brand drugs: 2,775 claims; generic drugs: 5,415 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria C Erazo $622 ($622 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $155.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $155 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $63.6 |
| Lilly USA, LLC LLY | 2 | $41.31 |
| GlaxoSmithKline, LLC. GSK | 1 | $31.93 |
| Mannkind Corporation MNKD | 1 | $22.12 |
| Insulet Corporation PODD | 1 | $21.01 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.93 |
| OPKO Pharmaceuticals, LLC | 1 | $18.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.